Recipient Blood Pre-Transplant Transfusion Prolongs Hepatic Allograft Survival in Rats

Journal of Surgical Research

Volumn 135, Issue 1, 2006, Pages 52-60

  Wang, Feng Shan ^a   Yamaguchi, Yasuo ^a   Furuhashi, Takashi ^a   Uchino, Shinichiro ^a   Kihara, Shinichi ^b   Yamada, Shinwa ^c   Mori, Katsutaka ^a   Ogawa, Michio ^a  

^a KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

^b KUMAMOTO UNIVERSITY   (Japan)

^c UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

Author keywords

apoptosis; liver transplantation; pre transplant intraportal immunization

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BLOOD; BLOOD TRANSFUSION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL INFILTRATION; DRUG BLOOD LEVEL; GRAFT RECIPIENT; GRAFT SURVIVAL; LIVER CELL; LIVER TRANSPLANTATION; MALE; NONHUMAN; ORGAN DONOR; PENILE BLOOD VESSEL; PORTAL VEIN; PRIORITY JOURNAL; RAT; RECIPIENT; SURVIVAL RATE;

ANIMALS; APOPTOSIS; BLOOD TRANSFUSION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; GRAFT SURVIVAL; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-2; LIVER; LIVER TRANSPLANTATION; LYMPHOCYTE TRANSFUSION; MALE; PORTAL VEIN; RATS; RATS, INBRED ACI; RATS, INBRED LEW; RNA, MESSENGER; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 33747048641     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.04.005     Document Type: Article

References (39)

1. Yu S., Nakafusa Y., and Flye M.W. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance. Surgery 116 (1994) 229
2. Gorczynski R.M., Chen Z., Zeng H., and Fu X.M. A role for persisting antigen, antigen presentation, and ICAM-1 in increased renal graft survival after oral or portal vein donor-specific immunization. Transplantation 66 (1998) 339
3. Yamaguchi Y., Harland R.C., Wyble C., and Bollinger R.R. The role of class I major histocompatibility complex antigens in prolonging the survival of hepatic allografts in the rat. Transplantation 47 (1989) 171
4. Perez R.V., Swanson C., Morgan M., Erickson K., Hubbard N.E., and German J.B. Portal venous transfusion up-regulates Kupffer cell cyclooxygenase activity. A mechanism of immunosuppression in organ transplantation. Transplantation 64 (1997) 135
5. Yu S., Nakafusa Y., and Flye M.W. Portal vein administration of donor cells promotes peripheral allospecific hyporesponsiveness and graft tolerance. Surgery 116 (1994) 229
6. Yamaguchi Y., Goto M., Makino Y., et al. Prolonged survival of rat hepatic allografts pretreated with a single donor-specific blood transfusion (DST). The distribution of donor cells expressing class I major histocompatibility complex antigens in the recipient. J Surg Res 61 (1996) 23
7. Krams S.M., and Martinez O.M. Apoptosis as a mechanism of tissue injury in liver allograft rejection. Semin Liver Dis 18 (1998) 153
8. Qian S., Lu L., Fu F., et al. Apoptosis within spontaneously accepted mouse liver allografts. Evidence for deletion of cytotoxic T cells and implications for tolerance induction. J Immunol 158 (1997) 4654
9. Meyer D., Baumgardt S., Loeffeler S., et al. Apoptosis of T lymphocytes in liver and/or small bowel allografts during tolerance induction. Transplantation 66 (1998) 1530
10. Shirwan H., Wang H.K., Barwari L., Makowka L., and Cramer D.V. Pretransplant injection of allograft recipients with donor blood or lymphocytes permits allograft tolerance without the presence of persistent donor microchimerism. Transplantation 61 (1996) 1382
11. Perez R., Johnson J., Winkler J.D., et al. Kupffer cell-mediated lymphocyte apoptosis. A PGE2-dependent mechanism of portal venous transfusion-induced immunosuppression?. J Surg Res 78 (1998) 37
12. Sun Z., Wada T., Maemura K., et al. Hepatic allograft-derived Kupffer cells regulate T cell response in rats. Liver Transp 9 (2003) 489
13. Yamaguchi Y., Harland R.C., Wyble C., Mori K., and Bollinger R.R. Variable allograft responses to pretreatment with donor splenocytes treated with Mitomycin C in the rat. Transplantation 47 (1989) 360
14. Yamaguchi Y., Kikuchi N., Miyanari N., et al. A technique for orthotopic reduced-size hepatic transplantation combined with ex vivo liver cut down in the rat. Dig Dis Sci 41 (1996) 1713
15. National Institutes of Health. Guide for the care and use of laboratory animals (1985) Public Health Service, NIH Publication No. 86-23, Bethesda, Maryland
16. Banff schema for grading liver allograft rejection. An international consensus document. Anonymous. Hepatology 25 (1997) 658
17. Williams A.F., Galfre G., and Milstein C. Analysis of cell surfaces by xenogeneic myeloma-hybrid antibodies. Differentiation antigens of rat lymphocytes. Cell 12 (1977) 663
18. Brideau R.J., Carter P.B., McMaster W.R., Mason D.W., and Williams A.F. Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol 10 (1980) 609
19. Wight D.G.D. In: Calne R.Y. (Ed). Liver transplantation (1983), Grune & Stratton, London 289
20. Misumi M., Yamaguchi Y., Mori K., et al. In situ macrophage distribution in the hepatic allograft associated with rejection in the rat. J Surg Res 55 (1993) 115
21. Ruiz R., Fuller J., and Sanfilippo F. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients. Transplantation 49 (1990) 175
22. Frohman M.A., Dush M.K., and Martin G.R. Rapid amplification of full- length cDNA from rare transcripts. Amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci USA 85 (1988) 8998
23. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156
24. Wrenshall L.E., Ansite J.D., Eckman P.M., Heilman M.J., Stevens R.B., and Sutherland D.E. Modulation of immune responses after portal venous injection of antigen. Transplantation 71 (2001) 841
25. Crispe I.N., Dao T., Klugewitz K., Mehal W.Z., and Metz D.P. The liver as a site of T-cell apoptosis. Graveyard, or killing field?. Immunol Rev 174 (2000) 47
26. Clouston A.D., Jonsson J.R., Balderson G.A., et al. Lymphocyte apoptosis and cell replacement in human liver allografts. Transplantation 73 (2002) 1828
27. Muschen M., Warskulat U., Peters-Regehr T., Bode J.G., Kubitz R., and Haussinger D. Involvement of CD95 (Apo-1/Fas) ligand expressed by rat Kupffer cells in hepatic immunoregulation. Gastroenterology 116 (1999) 666
28. Crispe I.N. Hepatic T cells and liver tolerance. Nat Rev Immunol 3 (2003) 51
29. Delfs M.W., Furukawa Y., Mitchell R.N., and Lichtman A.H. CD8+ T cell subsets TC1 and TC2 cause different histopathologic forms of murine cardiac allograft rejection. Transplantation 71 (2001) 606
30. Yamaguchi Y., Miyanari N., Ichiguchi O., et al. Infiltrating CD45RC- T cells are associated with immunologic unresponsiveness induced by donor class I major histocompatibility complex antigen in rats. Hepatology 28 (1998) 450
31. Tung T.C., Oshima K., Cui G., Laks H., and Sen L. Dual upregulation of Fas and Bax promotes alloreactive T cell apoptosis in IL-10 gene targeting of cardiac allografts. Am J Physiol Heart Circ Physiol 285 (2003) H964
32. Marra L.E., Zhang Z.X., Joe B., et al. IL-10 induces regulatory T cell apoptosis by up-regulation of the membrane form of TNF-α. J Immunol 172 (2004) 1028
33. Oshima K., Sen L., Cui G., et al. Localized interleukin-10 gene transfer induces apoptosis of alloreactive T cells via FAS/FASL pathway, improves function, and prolongs survival of cardiac allograft. Transplantation 73 (2002) 1019
34. Calder V.L., Bondeson J., Brennan F.M., Foxwell B.M., and Feldmann M. Antigen-specific T-cell downregulation by human dendritic cells following blockade of NF-kappaB. Scand J Immunol 57 (2003) 261
35. Roberts A.I., Devadas S., Zhang X., et al. The role of activation-induced cell death in the differentiation of T-helper-cell subsets. Immunol Res 28 (2003) 285
36. Refaeli Y., Van Parijs L., Alexander S.I., and Abbas A.K. Interferon gamma is required for activation-induced death of T lymphocytes. J Exp Med 196 (2002) 999
37. Schroder K., Hertzog P.J., Ravasi T., and Hume D.A. Interferon-γ. An overview of signals, mechanisms and functions. J Leukoc Biol 75 (2004) 163
38. Li J.H., Kluger M.S., Madge L.A., Zheng L., Bothwell A.L., and Pober J.S. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis. Am J Pathol 161 (2002) 1485
39. Refaeli Y., Van Parijs L., Alexander S.I., and Abbas A.K. Interferon γ is required for activation-induced death of T lymphocytes. J Exp Med 196 (2002) 999